{
    "2019-04-06": [
        [
            {
                "time": "2019-10-15",
                "original_text": "Lawsuit over migraine deal could be good for Amgen, analysts say",
                "features": {
                    "keywords": [
                        "lawsuit",
                        "migraine",
                        "Amgen",
                        "analysts"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-01",
                "original_text": "Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Ibrance",
                        "FDA",
                        "approval",
                        "breast cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}